Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00036972
First received: May 13, 2002
Last updated: June 25, 2013
Last verified: December 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Primary Completion Date: January 2005 (Final data collection date for primary outcome measure)